- Home
- MHUA vs BFRI Comparison
MHUA vs BFRI Comparison
Compare MHUA & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- BFRI
- Stock Information
- Founded
- MHUA 1990
- BFRI 1997
- Country
- MHUA China
- BFRI United States
- Employees
- MHUA N/A
- BFRI N/A
- Industry
- MHUA Medical Specialities
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- MHUA Health Care
- BFRI Health Care
- Exchange
- MHUA Nasdaq
- BFRI Nasdaq
- Market Cap
- MHUA 10.2M
- BFRI 8.7M
- IPO Year
- MHUA 2022
- BFRI 2021
- Fundamental
- Price
- MHUA $0.32
- BFRI $0.77
- Analyst Decision
- MHUA
- BFRI Strong Buy
- Analyst Count
- MHUA 0
- BFRI 1
- Target Price
- MHUA N/A
- BFRI $7.00
- AVG Volume (30 Days)
- MHUA 56.5K
- BFRI 90.9K
- Earning Date
- MHUA 04-23-2025
- BFRI 03-21-2025
- Dividend Yield
- MHUA N/A
- BFRI N/A
- EPS Growth
- MHUA 29.93
- BFRI N/A
- EPS
- MHUA 0.37
- BFRI N/A
- Revenue
- MHUA $94,252,537.00
- BFRI $37,321,000.00
- Revenue This Year
- MHUA N/A
- BFRI $28.62
- Revenue Next Year
- MHUA N/A
- BFRI $27.07
- P/E Ratio
- MHUA $0.90
- BFRI N/A
- Revenue Growth
- MHUA N/A
- BFRI 9.54
- 52 Week Low
- MHUA $0.25
- BFRI $0.65
- 52 Week High
- MHUA $1.47
- BFRI $2.43
- Technical
- Relative Strength Index (RSI)
- MHUA 44.05
- BFRI 33.18
- Support Level
- MHUA $0.33
- BFRI $0.77
- Resistance Level
- MHUA $0.36
- BFRI $0.96
- Average True Range (ATR)
- MHUA 0.02
- BFRI 0.08
- MACD
- MHUA -0.00
- BFRI -0.01
- Stochastic Oscillator
- MHUA 12.50
- BFRI 2.70
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.